OcrelizumabLate onset neutropenia: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1842卷 / 1期

关键词：

D O I：

10.1007/s40278-021-91024-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：288 / 288

相关论文

共 50 条

[31] FingolimodLymphopenia and neutropenia: 3 case reports
Reactions Weekly, 2015, 1538 (1) : 110 - 110
[32] OlaparibAnaemia and neutropenia: 3 case reports
Reactions Weekly, 2024, 2023 (1) : 335 - 335
[33] FingolimodLymphopenia and neutropenia: 3 case reports
Reactions Weekly, 2014, 1510 (1) : 23 - 23
[34] RituximabGrade IV late onset neutropenia: 2 case reports
Reactions Weekly, 2019, 1782 (1) : 279 - 279
[35] RituximabLate-onset neutropenia and leucopenia: 2 case reports
Reactions Weekly, 2015, 1551 (1) : 210 - 210
[36] Bortezomib/melphalanFebrile neutropenia, neutropenia and thrombocytopenia: 3 case reports
Reactions Weekly, 2021, 1839 (1) : 68 - 68
[37] HydroxycarbamideReticulocytopenia, thrombocytopenia and neutropenia: 3 case reports
Reactions Weekly, 2018, 1685 (1) : 99 - 99
[38] Palbociclib/ribociclibHepatotoxicity and neutropenia: 3 case reports
Reactions Weekly, 2020, 1834 (1) : 215 - 215
[39] Allopurinol/mercaptopurineHepatotoxicity and neutropenia: 3 case reports
Reactions Weekly, 2020, 1810 (1) : 21 - 21
[40] Gemcitabine/paclitaxelFebrile neutropenia: 3 case reports
Reactions Weekly, 2021, 1873 (1) : 119 - 119

← 1 2 3 4 5 →